Retrospective observational study reports high two-year patency following hybrid revascularization in peripheral arterial disease, highlighting its safety for multi-level vascular lesions.
Objective:The objective of the study was to present patients with peripheral vascular disease (PVD) who underwent hybrid procedures at our institution, the results of these interventions for a 5-year period and determine patency, mortality, failure, and amputation rates compared to the literature.Material and Methods: Observational, single center, retrospective, and crosssectional study which analyzed data gathered from the vascular quality initiative from patients who had hybrid revascularization procedures from January 2010 to December 2015.Results: 87 patients were identified: 51 (58%) male, 36 (41%) female, 9 (10%) had critical limb ischemia (CLI), and 78 (90%) claudication.We analyzed results of hybrid interventions in their variations.Technical success rate was 100%, patency at 2 years 88.5% (primary 65%, primary-assisted 18.3%, and secondary 4.5%) and 11.49% failure rate (lost patency < 1 year, conversion to open or/and amputation).Predictors of failure were: Female, previous chronic heart failure, longer length of stay, and previously transferred from another hospital.Amputation rate was 12.6% (10.3% major and 2.2% minor amputation), the only significant predictor was age (p = 0.035, odds ratio = 0.89) (0.806-99).Conclusions: Hybrid procedures are effective to treat patients with either CLI or claudication.Our study had outcomes comparable to the literature, with similar patency, amputation, and complication rates.We conclude it is a safe and effective option for PVD with multi-level disease.
No takes yet. Share an insight, caveat, or question.
Leo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: